1. Integration of molecular targeted therapy with radiation in head and neck cancer
   Yu Du et al, 2014, Pharmacology & Therapeutics CrossRef
2. Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with131I-tositumomab
   Rebecca L. Elstrom et al, 2015, Leukemia & Lymphoma CrossRef
3. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo
   WEIWEI TANG et al, 2014, International Journal of Oncology CrossRef
4. Overcoming radioresistance in head and neck squamous cell carcinoma
   Vicky N. Yamamoto et al, 2016, Oral Oncology CrossRef
5. Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention
   Sharmistha Dey et al, 2022, Medical Oncology CrossRef
6. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer
   Jana Kern et al, 2024, Radiotherapy and Oncology CrossRef
7. Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches
   Jason I. Kass et al, 2014, Resistance to Proteasome Inhibitors in Cancer CrossRef
8. Preliminary evaluation of prostate-targeted radiotherapy using 131I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs†
   Mathias Tesson et al, 2016, Journal of Pharmacy and Pharmacology CrossRef
9. In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity
   Steve Seltzsam et al, 2019, Translational Oncology CrossRef
10. Small-molecule drug repurposing to target DNA damage repair and response pathways
    Jacqueline A. Brinkman et al, 2021, Seminars in Cancer Biology CrossRef
11. Bortezomib prevents the expression of MMP-13 and the degradation of collagen type 2 in human chondrocytes
    Weihua Hu et al, 2014, Biochemical and Biophysical Research Communications CrossRef
12. Activation of Cell Surface Bound 20S Proteasome Inhibits Vascular Cell Growth and Arteriogenesis
    Wulf D. Ito et al, 2015, BioMed Research International CrossRef
13. Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines
    Masaharu Hazawa et al, 2020, Cancers CrossRef
14. Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine
    Saurabh Bundela et al, 2015, PLOS ONE CrossRef
15. NF‐κB acts as a multifunctional modulator in bone invasion by oral squamous cell carcinoma
    Eijiro Jimi et al, 2016, Oral Science International CrossRef
16. Supramolecular nanoscale assemblies for cancer diagnosis and therapy
    Sílvia Castro Coelho et al, 2015, Journal of Controlled Release CrossRef
17. Targeted Therapy in Solid Tumors: Head and Neck
    Marcus M. Monroe et al, 2015, Targeted Therapy in Translational Cancer Research CrossRef